Drug intelligence / Profile preview

ephedrine + phenylephrine

Development stage
Phase 4
Lead developer
Talphera
Modality
Small Molecules
Administration
Intravenous
01

Overview

Ephedrine + phenylephrine is a combination of two sympathomimetic agents used primarily to prevent and treat hypotension during spinal anesthesia, particularly in cesarean sections. The combination leverages complementary mechanisms: ephedrine acts as both a direct and indirect sympathomimetic with mixed α and β effects, while phenylephrine is predominantly an α-adrenergic agonist. This combination allows for lower doses of each individual drug, potentially reducing side effects while maintaining efficacy. The physiologic rationale for combining these agents is to increase the α/β-agonist activity ratio, where ephedrine's positive chronotropic and inotropic effects may counter the reflex decreases in heart rate and cardiac output that phenylephrine can induce.

Other names
ephedrine and phenylephrine combination
02

Targets

ADRA1A (α1A)ADRB1 (β1)NET (Norepinephrine Transporter)ADRA1 (Alpha-1 adrenergic receptor family)

Beyond the preview

Go deeper on ephedrine + phenylephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ephedrine + phenylephrine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call